Guidelines on the use of therapeutic apheresis in clinical practice–evidence‐based approach from the writing committee of the American society for apheresis: the …

J Schwartz, A Padmanabhan, N Aqui… - Journal of clinical …, 2016 - Wiley Online Library
The American Society for Apheresis (ASFA) Journal of Clinical Apheresis (JCA) Special
Issue Writing Committee is charged with reviewing, updating, and categorizing indications …

Update on morphea: part I. Epidemiology, clinical presentation, and pathogenesis

N Fett, VP Werth - Journal of the American Academy of Dermatology, 2011 - Elsevier
Morphea, also known as localized scleroderma, is a rare fibrosing disorder of the skin and
underlying tissues. Morphea is differentiated from systemic sclerosis based on the absence …

Guidelines on the Use of therapeutic apheresis in clinical practice–Evidence‐Based approach from the Writing Committee of the American Society for Apheresis: The …

L Connelly‐Smith, CR Alquist, NA Aqui… - Journal of clinical …, 2023 - Wiley Online Library
Abstract The American Society for Apheresis (ASFA) Journal of Clinical Apheresis (JCA)
Special Issue Writing Committee is charged with reviewing, updating, and categorizing …

Guidelines on the use of therapeutic apheresis in clinical practice–evidence‐based approach from the Writing Committee of the American Society for Apheresis: the …

A Padmanabhan, L Connelly‐Smith… - Journal of clinical …, 2019 - Wiley Online Library
ABSTRACT The American Society for Apheresis (ASFA) Journal of Clinical Apheresis (JCA)
Special Issue Writing Committee is charged with reviewing, updating and categorizing …

Guidelines on the use of therapeutic apheresis in clinical practice—evidence‐based approach from the Writing Committee of the American Society for Apheresis: the …

J Schwartz, JL Winters, A Padmanabhan… - Journal of clinical …, 2013 - Wiley Online Library
The American Society for Apheresis (ASFA) JCA Special Issue Writing Committee is
charged with reviewing, updating and categorizating indications for therapeutic apheresis …

European Dermatology Forum S1‐guideline on the diagnosis and treatment of sclerosing diseases of the skin, Part 1: localized scleroderma, systemic sclerosis and …

R Knobler, P Moinzadeh, N Hunzelmann… - Journal of the …, 2017 - Wiley Online Library
The term 'sclerosing diseases of the skin'comprises specific dermatological entities, which
have fibrotic changes of the skin in common. These diseases mostly manifest in different …

Guidelines on the use of extracorporeal photopheresis

R Knobler, G Berlin, P Calzavara‐Pinton… - Journal of the …, 2014 - Wiley Online Library
Background After the first investigational study on the use of extracorporeal photopheresis
for the treatment of cutaneous T‐cell lymphoma was published in 1983 with its subsequent …

Update on morphea: part II. Outcome measures and treatment

N Fett, VP Werth - Journal of the American Academy of Dermatology, 2011 - Elsevier
Morphea is a rare fibrosing disorder of the skin and underlying tissues. The underlying
pathogenesis of morphea is not completely understood at this time, but ultimately results in …

[HTML][HTML] Extracorporeal photopheresis—an overview

A Cho, C Jantschitsch, R Knobler - Frontiers in medicine, 2018 - frontiersin.org
Extracorporeal photopheresis (ECP) has been in clinical use for over three decades after
receiving FDA approval for the palliative treatment of the Sézary Syndrome variant of …

European dermatology forum: Updated guidelines on the use of extracorporeal photopheresis 2020–Part 2

R Knobler, P Arenberger, A Arun… - Journal of the …, 2021 - Wiley Online Library
Background Following the first investigational study on the use of extracorporeal
photopheresis for the treatment of cutaneous T‐cell lymphoma published in 1983, this …